OliX Pharmaceuticals, Inc (KOSDAQ:226950)
140,400
+400 (0.29%)
Dec 30, 2025, 3:30 PM KST
724.91% (1Y)
| Market Cap | 2.82T |
| Revenue (ttm) | 10.18B |
| Net Income (ttm) | -43.30B |
| Shares Out | 20.11M |
| EPS (ttm) | -2,280.15 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 419,758 |
| Average Volume | 903,039 |
| Open | 140,000 |
| Previous Close | 140,000 |
| Day's Range | 136,400 - 141,000 |
| 52-Week Range | 13,380 - 148,700 |
| Beta | 0.50 |
| RSI | 57.93 |
| Earnings Date | Mar 19, 2026 |